Stony Brook’s Gynecologic Oncology Team provides comprehensive, multidisciplinary care to women with known or suspected gynecologic cancers, including cancers of the: • ovaries • uterus (endometrium) • cervix • vulva • vagina • peritoneum • fallopian tubes.
The Gynecologic Oncology Team also provides care to women with complicated gynecologic surgical needs. Conditions that are considered preinvasive such as dysplasia (a change to the lining of the cervix) are also treated by this team. Diagnostic testing, counseling and treatment are provided for those with a genetic predisposition to cancer, including breast cancer (BRCA) gene mutations and Lynch syndrome.
Led by a board-certified gynecologic oncologist, this highly experienced team treats more than 650 new patients, performs over 400 surgical procedures, administers 625 chemotherapy cycles, and totals over 4,000 office visits a year.
Key components of the team’s work are research and education. In conjunction with NRG- Oncology, a national research organization funded by the National Institutes of Health, team members provide patients access to cutting-edge therapy through clinical studies. Resident physicians in obstetrics and gynecology and medical students from Stony Brook School of Medicine participate in caring for patients, as well as contributing to the team’s research activities under the supervision of the attending physicians.